Everest Medicines Ltd. (HK:1952) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Everest Medicines Limited has announced the grant of 240,000 Options and 498,000 Awards to select employees and senior managers under their Post-IPO Share Option Scheme and Pre-IPO ESOP, respectively. The options, exercisable at HK$27.35, vest over four years and aim to attract, retain, and incentivize key personnel without specific performance targets. The grants are consistent with the company’s past practices and are designed to contribute to its overall business performance and corporate governance.
For further insights into HK:1952 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue